Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on BMS-955176 PK in Healthy Subjects
NCT02273947Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Oct 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of BMS-955176 in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Oct 2014; status: completed.
02
Drugs
BMS-955176
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02273947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273947.